Chikungunya vaccine candidate advances to a Phase 2 clinical trial

被引：0
|
作者：
不详
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2016年 / 12卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：2721 / 2721
页数：1
相关论文
共 50 条
  • [21] Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial
    Turner, Mark
    Papadimitriou, Athanasia
    Winkle, Peter
    Segall, Nathan
    Levin, Michael
    Doust, Matthew
    Johnson, Casey
    Lucksinger, Gregg
    Fierro, Carlos
    Pickrell, Paul
    Raanan, Marsha
    Tricou, Vianney
    Borkowski, Astrid
    Wallace, Derek
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (10) : 2456 - 2464
  • [22] Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial
    de Bruyn, Guy
    Saleh, Jamshid
    Workman, David
    Pollak, Richard
    Elinoff, Victor
    Fraser, Neil J.
    Lefebvre, Gigi
    Martens, Mark
    Mills, Richard E.
    Nathan, Richard
    Trevino, Miguel
    van Cleeff, Martin
    Foglia, Ginamarie
    Ozol-Godfrey, Ayca
    Patel, Dhaval M.
    Pietrobon, Patricia J.
    Gesser, Richard
    VACCINE, 2016, 34 (19) : 2170 - 2178
  • [23] DEVELOPMENT OF A CHIKUNGUNYA VACCINE CANDIDATE USING EILAT VIRUS AS A PLATFORM
    Erasmus, Jesse
    Rossi, Shannan
    Leal, Grace
    Kaelber, Jason
    Chiu, Wah
    Popov, Vsevolod
    Nasar, Farooq
    Weaver, Scott
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (04): : 43 - 43
  • [24] Amid Paraguay Chikungunya Outbreak, Vaccine Candidate Safe, Immunogenic
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (02): : 111 - 111
  • [25] Promising results from a phase 1 trial of a MERS vaccine candidate
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (09) : 2099 - 2099
  • [26] CMV vaccine candidate showed promising data in a Phase 1 trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (07) : 1545 - 1545
  • [27] Preliminary phase 1 results from an HIV vaccine candidate trial
    Venkatesan, Priya
    LANCET MICROBE, 2021, 2 (03): : E95 - E95
  • [28] Powdered Measles Vaccine advances to Phase 2
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (02) : 314 - 314
  • [29] In silico prediction and analysis of CTL epitopes of Chikungunya virus proteins for vaccine candidate against Chikungunya Virus
    Kumari, K.
    Kumar, J.
    Kumar, R.
    Kumar, M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 355 - 355
  • [30] A Randomized Controlled Phase Ib Trial of the Malaria Vaccine Candidate GMZ2 in African Children
    Belard, Sabine
    Issifou, Saadou
    Hounkpatin, Aurore B.
    Schaumburg, Frieder
    Ngoa, Ulysse Ateba
    Esen, Meral
    Fendel, Rolf
    de Salazar, Pablo Martinez
    Muerbeth, Raymund E.
    Milligan, Paul
    Imbault, Nathalie
    Imoukhuede, Egeruan Babatunde
    Theisen, Michael
    Jepsen, Soren
    Noor, Ramadhani A.
    Okech, Brenda
    Kremsner, Peter G.
    Mordmueller, Benjamin
    PLOS ONE, 2011, 6 (07):
12345